Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 27, 2023
Sublobar resection is not always superior for early-stage lung cancer in high-risk patientsMariko Fukui, Takeshi Matsunaga, Aritoshi Hattori, et al.
General Thoracic and Cardiovascular Surgery|July 7, 2020
Surgical results and prognosis of lung cancer in elderly Japanese patients aged over 85 years: comparison with patients aged 80-84 yearsHideomi Ichinokawa, Kazuya Takamochi, Mariko Fukui, et al.
Surgery Today|March 22, 2024
Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancerEisuke Goto, Aritoshi Hattori, Mariko Fukui, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 27, 2022
Pulmonary artery reconstruction for non-small cell lung cancer: Surgical management and long-term outcomesIsamu Watanabe, Aritoshi Hattori, Mariko Fukui, et al.
Surgery Today|August 23, 2025
Surgical outcomes of completion lobectomy after primary segmentectomyAritoshi Hattori, Takeshi Matsunaga, Mariko Fukui, et al.
General Thoracic and Cardiovascular Surgery|January 6, 2025
Proposal for novel definition of radiologically less-invasive clinical stage IA solid predominant lung adenocarcinoma using the maximum standardized uptake valueYukio Watanabe, Aritoshi Hattori, Mariko Fukui, et al.
Japanese Journal of Clinical Oncology|February 21, 2025
Clinical significance of 4 L lymphadenectomy in solid dominant clinical stage I non-small cell lung cancer in the left upper lobeYukio Watanabe, Aritoshi Hattori, Mariko Fukui, et al.
Seminars in Thoracic and Cardiovascular Surgery|September 30, 2022
Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung CancerAritoshi Hattori, Takeshi Matsunaga, Mariko Fukui, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 23, 2023
Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearanceAritoshi Hattori, Takeshi Matsunaga, Mariko Fukui, et al.
Pageof 11